Trans-4-[(9H-Fluoren-9-ylmethoxy)carbonylamino]cyclohexanecarboxylic acid is a protected amino acid derivative. Its structure features a trans-cyclohexane ring substituted with an Fmoc-protected amino group and a carboxylic acid group at the 1- and 4-positions, respectively. This configuration provides a rigid, alicyclic scaffold. This compound is primarily used as a specialized building block in solid-phase peptide synthesis (SPPS). The Fmoc group serves as a base-labile protecting group for the amine, while the carboxylic acid is activated for coupling to the growing peptide chain. Incorporating this constrained, non-natural amino acid analogue into peptide sequences is a common strategy to modulate the peptide's conformational flexibility, enhance metabolic stability, and improve binding affinity or selectivity towards biological targets, such as G-protein-coupled receptors (GPCRs) or enzymes. As a high-value synthetic intermediate, it is specifically designed for constructing peptides with specific structural and pharmacological properties, rather than being a general-purpose chemical reagent. Its applications are firmly rooted in medicinal chemistry and peptide-based drug discovery.